Skip to main content
. 2024 Jan 31;16(3):609. doi: 10.3390/cancers16030609

Figure 7.

Figure 7

Schematic drawing of the impact of TRPA1 depletion or pore-function inhibition on FGR2c/PKCε signaling and tumorigenic outcomes. The depletion of TRPA1 expression by siRNA, but not its functional block using the antagonist A967079, significantly repressed the FGR2c/PKCε axis and the enhancement of EMT, as well as the MCL-1-dependent increase in cell invasion.